CMTTdb

An integrated database for cancer molecular targeted thearpies

View Agent


Agent Info
Agent:SU5416
Synonyms:Semaxanib;Semaxinib;Semaxnib;Semoxind;S 8442;SU 5416;VEGF Receptor 2 Kinase Inhibitor III;InSolutionâ„¢ SU-5416;TSU-16;Semaxanib (USAN/INN);Methylene]-2H-indol-2-one;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one;(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one;1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl);1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one;3-((Z)-(3,5-Dimethylpyrrol-2-yl)methylene)-2-indolinone;3-(1-(3,5-Dimethyl-1H-pyrrol-2-yl)meth-(Z)-ylidene)-2-oxo-2,3-dihydroindole;3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one;3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one;3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]indolin-2-one;3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one
Drug Status For Certain Diseases:Multiple myeloma;HIV Infections …(phase II)
Classification:antiangiogenic agent
Target:Vascular endothelial growth factor
KEGG Pathway:NA
Wiki Pathway:NA